Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting-Reference-Cited by-同舟云学术

Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting

Published:2020-09 Issue: Volume:86 Page:106748
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

d'Alessandro Miriana,Perillo Felice,Metella Refini Rosa,Bergantini Laura,Bellisai Francesca,Selvi Enrico,Cameli Paolo,Manganelli Stefania,Conticini Edoardo,Cantarini Luca,Sestini Piersante,Frediani Bruno,Bargagli Elena

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference31 articles.

1. Effects of rituximab therapy on B cell differentiation and depletion;Bergantini;Clin. Rheumatol.,2020

2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update;Smolen;Ann. Rheum. Dis.,2017

3. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort;Koduri;Rheumatology (Oxford),2010

4. Rheumatoid arthritis-interstitial lung disease-associated mortality;Olson;Am. J. Respir. Crit. Care Med.,2011

5. Cardiovascular death in rheumatoid arthritis: a population-based study;Maradit-Kremers;Arthritis Rheum.,2005

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Krebs von den Lungen-6 as biomarker of the new progressive fibrotic phenotype of interstitial lung disease;Tissue and Cell;2024-10

2. Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis;Autoimmunity Reviews;2024-09

3. Fibrotic remodeling in joint diseases: induction and inhibition of fibrosis in fibroblast-like synoviocytes;Translational Medicine Communications;2024-06-01

4. JAK2 inhibitors improve RA combined with pulmonary fibrosis in rats by downregulating SMAD3 phosphorylation;International Journal of Rheumatic Diseases;2024-05

5. Baricitinib for anti-melanoma differentiation-associated protein 5 antibody-positive dermatomyositis-associated interstitial lung disease: a case series and literature review on Janus kinase inhibitors for the disease;Rheumatology International;2024-03-08